Asterriquinones could potentially treat neurodegenerative diseases such as Alzheimer’s and Parkinson’s by activating tyrosine kinases (TrkA, TrkB and TrkC) receptors [43,44,45]. Here, NTRK1 is linked to neurodegenerative disease.